Patents by Inventor Jossan Sukhwinder

Jossan Sukhwinder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical combination formulation and method of treatment with the combination
    Patent number: 6818639
    Abstract: The invention relates to method of preventing or treating a disease related to the 5-HT2C receptor and the 5-HT6 receptor, comprising administering to a human or animal subject in need thereof a 5-HT2C receptor agonist and a 5-HT6 receptor antagonist in sufficient amounts to provide a therapeutic effect. The invention also relates to a pharmaceutical composition comprising an effective amount of a combination of a 5-HT2C receptor agonist and a 5-HT6 receptor antagonist, and optionally a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: July 20, 2001
    Date of Patent: November 16, 2004
    Assignee: Biovitrum AB
    Inventors: Jossan Sukhwinder, Björn M. Nilsson, Kjell S. Sakariassen, Jan Svartengren
  • Pharmaceutical combination formulation and method of treatment with the combination
    Publication number: 20020068732
    Abstract: The invention relates to method of preventing or treating a disease related to the 5-HT2C receptor and the 5-HT6 receptor, comprising administering to a human or animal subject in need thereof a 5-HT2C receptor agonist and a 5-HT6 receptor antagonist in sufficient amounts to provide a therapeutic effect. The invention also relates to a pharmaceutical composition comprising an effective amount of a combination of a 5-HT2C receptor agonist and a 5-HT6 receptor antagonist, and optionally a pharmaceutically acceptable carrier.
    Type: Application
    Filed: July 20, 2001
    Publication date: June 6, 2002
    Inventors: Jossan Sukhwinder, Bjorn M. Nilsson, Kjell S. Sakariassen, Jan Svartengren